In around 9% of ABC-DLBCL (and a smaller subset of GCB-DLBCL), activation of BCR and NF-κB can be attributed to gain of function mutations within the coiled-coil domain of the CARD11/CARMA1 gene [44] component of the CBM complex. This evidence concerns the gene NFKB1 and aneurysmal bone cyst.